EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) is -27.92% lower on its value in year-to-date trading and has touched a low of $5.00 and a high of $23.65 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The EYPT stock was last observed hovering at around $5.05 in the last trading session, with the day’s gains setting it 0.32%.
Currently trading at $5.37, the stock is -15.21% and -19.51% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.08 million and changing 6.34% at the moment leaves the stock -35.85% off its SMA200. EYPT registered -73.51% loss for a year compared to 6-month loss of -32.79%. The firm has a 50-day simple moving average (SMA 50) of $6.672 and a 200-day simple moving average (SMA200) of $8.371.
The stock witnessed a -11.68% gain in the last 1 month and extending the period to 3 months gives it a -23.50%, and is -11.39% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.11% over the week and 7.80% over the month.
EyePoint Pharmaceuticals Inc (EYPT) has around 165 employees, a market worth around $369.07M and $43.27M in sales. Profit margin for the company is -302.43%. Distance from 52-week low is 7.40% and -77.29% from its 52-week high. The company has generated returns on investments over the last 12 months (-36.52%).
The EPS is expected to shrink by -22.68% this year
212.0 institutions hold shares in EyePoint Pharmaceuticals Inc (EYPT), with institutional investors hold 110.92% of the company’s shares. The shares outstanding are 68.27M, and float is at 59.62M with Short Float at 18.16%. Institutions hold 109.63% of the Float.
The top institutional shareholder in the company is CORMORANT ASSET MANAGEMENT, LP with over 8.32 million shares valued at $72.43 million. The investor’s holdings represent 15.6467 of the EYPT Shares outstanding. As of 2024-06-30, the second largest holder is SUVRETTA CAPITAL MANAGEMENT, LLC with 5.18 million shares valued at $45.03 million to account for 9.7279 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 3.76 million shares representing 7.076 and valued at over $32.75 million, while FRANKLIN RESOURCES INC holds 6.8595 of the shares totaling 3.65 million with a market value of $31.75 million.
EyePoint Pharmaceuticals Inc (EYPT) Insider Activity
Still, SEC filings show that on Aug 20 ’24, DICICCO WENDY F (Director) acquired 2,567 shares at an average price of $7.79 for $19997.0. The insider now directly holds 9,967 shares of EyePoint Pharmaceuticals Inc (EYPT).
